Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miaki Makiguchi"'
Autor:
Daisuke Negishi, Okimichi Mitsumatsu, Hiromi Mitsumatsu, Miaki Makiguchi, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background Tedizolid is a new oxazolidinone antibiotic with high potency for the treatment of infections caused by methicillin-resistant Staphylococcus aureus and other species. Case presentation Two patients with osteoarthritis (women aged
Externí odkaz:
https://doaj.org/article/f44eb9d31c544ba59c0e3f2737e98059
Autor:
Daisuke Negishi, Okimichi Mitsumatsu, Takahiro Matsumura, Hiromi Mitsumatsu, Miaki Makiguchi, Makiko Shimizu, Hiroshi Yamazaki
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Linezolid is a new oxazolidinone antibiotic used for infections caused by methicillin-resistant Staphylococcus and other species. Case presentation Two cases of knee osteoarthritis with acute infection were successfully treated us
Externí odkaz:
https://doaj.org/article/e006239560d74fc98cb1bda85851c857
Autor:
Makiko Shimizu, Akane Yamamoto, Miaki Makiguchi, Erika Shimamura, Yuka Yokota, Mizuki Harano, Hiroshi Yamazaki
Publikováno v:
Drug Metabolism and Pharmacokinetics. 50:100490
Autor:
Yasuhiro Uno, Makiko Shimizu, Yurie Ogawa, Miaki Makiguchi, Hiroaki Kawaguchi, Osamu Yamato, Mayumi Ishizuka, Hiroshi Yamazaki
Publikováno v:
Biochemical pharmacology. 202
Flavin-containing monooxygenases (FMOs) are drug-oxygenating enzymes that are present in the human genome as FMO1-5 and FMO6P. Among pig, dog, and cat FMOs, pig and dog FMO1 and FMO3 have been partly characterized, but other FMOs have not been system
Autor:
Miaki Makiguchi, Makiko Shimizu, Yuka Yokota, Erika Shimamura, Eiji Hishinuma, Sakae Saito, Masahiro Hiratsuka, Hiroshi Yamazaki
Publikováno v:
Drug Metabolism and Disposition. :DMD-AR
Autor:
Makiko Shimizu, Nagisa Hirose, Mao Kato, Haruna Sango, Yumi Uenuma, Miaki Makiguchi, Eiji Hishinuma, Sakae Saito, Masahiro Hiratsuka, Hiroshi Yamazaki
Publikováno v:
Drug Metabolism and Pharmacokinetics. 46:100465
The number of single-nucleotide substitutions of human flavin-containing monooxygenase 3 (FMO3) recorded in mega-databases is increasing. Moreover, phenotype-gene analyses have revealed impaired FMO3 variants associated with the metabolic disorder tr